<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>3</volume><submitter>Mabalirajan U</submitter><pubmed_abstract>The mechanisms underlying asthmatic airway epithelial injury are not clear. 12/15-lipoxygenase (an ortholog of human 15-LOX-1), which is induced by IL-13, is associated with mitochondrial degradation in reticulocytes at physiological conditions. In this study, we showed that 12/15-LOX expressed in nonepithelial cells caused epithelial injury in asthma pathogenesis. While 12/15-LOX overexpression or IL-13 administration to naïve mice showed airway epithelial injury, 12/15-LOX knockout/knockdown in allergic mice reduced airway epithelial injury. The constitutive expression of 15-LOX-1 in bronchial epithelia of normal human lungs further indicated that epithelial 15-LOX-1 may not cause epithelial injury. 12/15-LOX expression is increased in various inflammatory cells in allergic mice. Though non-epithelial cells such as macrophages or fibroblasts released 12/15-LOX metabolites upon IL-13 induction, bronchial epithelia didn't release. Further 12-S-HETE, arachidonic acid metabolite of 12/15-LOX leads to epithelial injury. These findings suggested 12/15-LOX expressed in non-epithelial cells such as macrophages and fibroblasts leads to bronchial epithelial injury.</pubmed_abstract><journal>Scientific reports</journal><pagination>1540</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3607899</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>12/15-lipoxygenase expressed in non-epithelial cells causes airway epithelial injury in asthma.</pubmed_title><pmcid>PMC3607899</pmcid><pubmed_authors>Ghosh B</pubmed_authors><pubmed_authors>Leishangthem GD</pubmed_authors><pubmed_authors>Dinda AK</pubmed_authors><pubmed_authors>Ahmad T</pubmed_authors><pubmed_authors>Biswal S</pubmed_authors><pubmed_authors>Rehman R</pubmed_authors><pubmed_authors>Singh S</pubmed_authors><pubmed_authors>Mabalirajan U</pubmed_authors><pubmed_authors>Agrawal A</pubmed_authors><pubmed_authors>Kumar S</pubmed_authors></additional><is_claimable>false</is_claimable><name>12/15-lipoxygenase expressed in non-epithelial cells causes airway epithelial injury in asthma.</name><description>The mechanisms underlying asthmatic airway epithelial injury are not clear. 12/15-lipoxygenase (an ortholog of human 15-LOX-1), which is induced by IL-13, is associated with mitochondrial degradation in reticulocytes at physiological conditions. In this study, we showed that 12/15-LOX expressed in nonepithelial cells caused epithelial injury in asthma pathogenesis. While 12/15-LOX overexpression or IL-13 administration to naïve mice showed airway epithelial injury, 12/15-LOX knockout/knockdown in allergic mice reduced airway epithelial injury. The constitutive expression of 15-LOX-1 in bronchial epithelia of normal human lungs further indicated that epithelial 15-LOX-1 may not cause epithelial injury. 12/15-LOX expression is increased in various inflammatory cells in allergic mice. Though non-epithelial cells such as macrophages or fibroblasts released 12/15-LOX metabolites upon IL-13 induction, bronchial epithelia didn't release. Further 12-S-HETE, arachidonic acid metabolite of 12/15-LOX leads to epithelial injury. These findings suggested 12/15-LOX expressed in non-epithelial cells such as macrophages and fibroblasts leads to bronchial epithelial injury.</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013</publication><modification>2025-04-18T14:15:58.741Z</modification><creation>2019-03-27T01:06:37Z</creation></dates><accession>S-EPMC3607899</accession><cross_references><pubmed>23528921</pubmed><doi>10.1038/srep01540</doi></cross_references></HashMap>